Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 22;728:138859.
doi: 10.1016/j.scitotenv.2020.138859. Online ahead of print.

Overview of Covid-19; Its Prevention and Management in the Light of Unani Medicine

Affiliations
Free PMC article

Overview of Covid-19; Its Prevention and Management in the Light of Unani Medicine

Sadia Nikhat et al. Sci Total Environ. .
Free PMC article

Abstract

Since December 2019, a respiratory pandemic named as coronavirus disease 2019 (Covid-19) caused by a new coronavirus named as SARS-CoV-2, has taken the world by storm. The symptoms are fever, malaise, and cough which resolve in a few days in most cases; but may progress to respiratory distress and organ failure. Transmission is through droplet infection or fomites, but other modes such as airborne transmission and oro-fecal transmission are also speculated. Research is underway to develop effective vaccines and medicines for the disease. In such a scenario, we present the measures described in Unani system of medicine for health protection during epidemics. Unani is a traditional system of medicine developed during the middle ages, which employs natural drugs of herbal, animal and mineral origin for treatment. In Unani medicine, during an epidemic, apart from isolation and quarantine, three measures are of utmost importance, (i) purification of surroundings using certain herbal drugs as fumigants or sprays, (ii) health promotion and immune-modulation, and (iii) use of health-protecting drugs and symptom-specific drugs. Drugs such as loban (Styrax benzoides W. G. Craib), sandroos (Hymenaea verrucosa Gaertn.) za'fran (Crocus sativus L.), vinegar etc. are prescribed in various forms. Scientific researches on these drugs reveal the presence of a number of pharmacologically active substances, which may provide a new insight into the management of infections and epidemics.

Keywords: Covid-19; Influenza; Nazla-e-wabaiya; SARS-CoV-2; Unani medicine; Waba.

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Similar articles

See all similar articles

References

    1. Acharya K.P. Resource poor countries ought to focus on early detection and containment of novel corona virus at the point of entry. Clin. Epidemiol. Glob. Heal. 2020 doi: 10.1016/j.cegh.2020.03.001. - DOI - PMC - PubMed
    1. Adedeji W.A. The treasure called antibiotics. Ann. Ibadan Postgrad. Med. 2016;14:56–57. - PMC - PubMed
    1. Al-Massarani S.M., El Gamal A.A., Alam P., Al-Sheddi E.S., Al-Oqail M.M., Farshori N.N. Isolation, biological evaluation and validated HPTLC-quantification of the marker constituent of the edible Saudi plant Sisymbrium irio L. Saudi Pharm. J. SPJ Off. Publ. Saudi Pharm. Soc. 2017;25:750–759. doi: 10.1016/j.jsps.2016.10.012. - DOI - PMC - PubMed
    1. Amini M., Ghoranneviss M., Abdijadid S. Effect of cold plasma on crocin esters and volatile compounds of saffron. Food Chem. 2017;235:290–293. doi: 10.1016/j.foodchem.2017.05.067. - DOI - PubMed
    1. Andersen K.G., Rambaut A., Lipkin W.I., Holmes E.C., Garry R.F. The proximal origin of SARS-CoV-2. Nat. Med. 2020 doi: 10.1038/s41591-020-0820-9. - DOI - PMC - PubMed

LinkOut - more resources

Feedback